Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BL, ? 4.8mm RC, SLActive 12mm, TiZr, NTP: medical device reports filed with FDA

1,854 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

1,854
device reports naming the brand
0% of all MAUDE reports · about 268 a year
165
reports, 12 months to August 2026
244 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

1,854 medical device reports received by FDA name the brand "BL, ? 4.8mm RC, SLActive 12mm, TiZr, NTP" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from August 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

165 reports arrived in the 12 months to August 2026, down 32% from 244 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (59.9%), loss of osseointegration (23.6%) and difficult to insert (2.9%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

02346Sep 2021: 28Oct 2021: 46Nov 2021: 32Dec 2021: 222022Jan 2022: 24Feb 2022: 13Mar 2022: 21Apr 2022: 15May 2022: 21Jun 2022: 9Jul 2022: 21Aug 2022: 21Sep 2022: 30Oct 2022: 21Nov 2022: 16Dec 2022: 302023Jan 2023: 19Feb 2023: 17Mar 2023: 11Apr 2023: 21May 2023: 17Jun 2023: 19Jul 2023: 20Aug 2023: 17Sep 2023: 23Oct 2023: 26Nov 2023: 12Dec 2023: 152024Jan 2024: 17Feb 2024: 26Mar 2024: 14Apr 2024: 24May 2024: 23Jun 2024: 16Jul 2024: 11Aug 2024: 36Sep 2024: 18Oct 2024: 30Nov 2024: 17Dec 2024: 92025Jan 2025: 31Feb 2025: 14Mar 2025: 27Apr 2025: 21May 2025: 0Jun 2025: 42Jul 2025: 19Aug 2025: 16Sep 2025: 8Oct 2025: 18Nov 2025: 14Dec 2025: 192026Jan 2026: 18Feb 2026: 7Mar 2026: 8Apr 2026: 12May 2026: 13Jun 2026: 15Jul 2026: 16Aug 2026: 17

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01513022019: 21520192020: 30220202021: 30220212022: 24220222023: 21720232024: 24120242025: 22920252026: 1062026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%1,854
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report80.4%1,490
Voluntary report0%0
User facility report0%0
Distributor report19.6%364
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate1,11159.9%62.8%
Loss of osseointegration43723.6%22.4%
Difficult to insertthe device was hard to insert542.9%0.4%
Fracturea broken bone100.5%1.6%
Unstable60.3%0%
Separation failure40.2%0.1%
Difficult to removethe device was hard to remove30.2%0%
Activation, positioning or separation problem20.1%0%
Insufficient device problem information10.1%0.2%
Therapeutic or diagnostic output failure10.1%0%
Unintended movement10.1%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis44223.8%
Painpain, site not specified37520.2%
Tissue damage33418%
Inflammationinflammation1719.2%
Swelling/ edema1065.7%
Hemorrhage/blood loss/bleeding824.4%
Abscessa collection of pus583.1%
Hyperresponsive to stimuli462.5%
Hypersensitivity/allergic reaction392.1%
Fistula351.9%
Increased sensitivity221.2%
Failure of implant201.1%
Swellingswelling181%
Numbnessnumbness120.6%
Inadequate osseointegration30.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBL, ? 4.8mm RC, SLActive 12mm, TiZr, NTPProduct code DZEAll MAUDE reports
Reports1,8543,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer80.4%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BL, ? 4.8mm RC, SLActive 12mm, TiZr, NTP reports

How many FDA reports name BL, ? 4.8mm RC, SLActive 12mm, TiZr, NTP?

1,854 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 165 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (59.9%), loss of osseointegration (23.6%), difficult to insert (2.9%), fracture (0.5%) and unstable (0.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (80.4%) and distributor reports (19.6%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BL, ? 4.8mm RC, SLActive 12mm, TiZr, NTP was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.